Assessing the Impact of GLP-1RAs on Cardiovascular and Renal Outcomes
The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled t ...